Displaying drugs 9276 - 9300 of 9894 in total
Acefylline
Experimental
Methylatropine
Experimental
CoA-S-trimethylene-acetyl-tryptamine
Experimental
Trifluoroacetonyl coenzyme A
Experimental
Myristoyl-Coa
Experimental
Dodecyl-Coa
Experimental
Penimepicycline
Penimepicycline is a tetracycline-class antibiotic. It is mentioned on List A produced by the Government of Canada, which is a list of antimicrobial active pharmaceutical ingredients . In the classification of the active ingredients included on this list, the classification document states that tetracycline class antibiotics are of medium importance,...
Experimental
Nitromethyldethia coenzyme A
Experimental
Etarfolatide
Etarfolatide has been used in trials studying the treatment and diagnostic of Breast Neoplasms, Non Small Cell Lung Cancer, and Adenocarcinoma of the Lung.
Investigational
TAK-448
TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.
Investigational
TRV-120027
TRV120027 has been used in trials studying the treatment of Heart Failure and Kidney Disease.
Investigational
Proglumetacin
Experimental
Domoic Acid
Experimental
3-Tyrosine
Experimental
4-Iodo-L-phenylalanine
Experimental
Trifluoromethionine
Experimental
Cp-Coeleneterazine
Experimental
CRA_9678
Experimental
Ispinesib
Investigational
Muraglitazar
Muraglitazar (Bristol-Myers Squibb/Merck) is a new agent under investigation for the treatment of patients with type 2 diabetes. It belongs to a novel class of drugs that target the peroxisome proliferator-activated receptors, both alpha and gamma subtypes. In addition to improvements in blood glucose and hemoglobin A1c (HbA1c), muraglitazar treatment...
Investigational
Displaying drugs 9276 - 9300 of 9894 in total